https://www.indianpharmapost.com/zydus-receives-fdas-odd-for-desidustat-for-the-treatment-of-beta-thalassemia-181532025-11-06T00:00:00+05:30always0.9https://www.indianpharmapost.com/bayers-finerenone-approved-in-india-for-heart-failure-181662025-11-06T00:00:00+05:30always0.9https://www.indianpharmapost.com/fda-approves-ucbs-kygevvi-for-rare-genetic-mitochondrial-disease-tk2-deficiency-181652025-11-06T00:00:00+05:30always0.9https://www.indianpharmapost.com/jj-medtech-reports-strong-one-year-results-for-shockwave-peripheral-ivl-system-in-disrupt-btk-ii-trial-181642025-11-06T00:00:00+05:30always0.9https://www.indianpharmapost.com/eli-lilly-to-invest-12-billion-in-puerto-rico-to-boost-us-oral-medicine-production-181632025-11-06T00:00:00+05:30always0.9https://www.indianpharmapost.com/redhill-secures-final-105m-court-judgment-for-enforcement-181622025-11-06T00:00:00+05:30always0.9https://www.indianpharmapost.com/sumitomo-pharma-america-unveils-promising-new-leukemia-and-myelofibrosis-data-ahead-of-ash-2025-181612025-11-06T00:00:00+05:30always0.9https://www.indianpharmapost.com/ginkgo-bioworks-and-bayer-renew-partnership-to-power-the-next-wave-of-ag-biologicals-181602025-11-06T00:00:00+05:30always0.9https://www.indianpharmapost.com/marksans-pharmas-uk-arm-relonchem-secures-mhra-nod-for-exemestane-25mg-tablets-181592025-11-06T00:00:00+05:30always0.9https://www.indianpharmapost.com/cupid-bags-largest-share-in-south-africas-5-year-national-condom-program-181582025-11-06T00:00:00+05:30always0.9https://www.indianpharmapost.com/eazebio-and-uc-santa-cruz-partner-to-advance-instrument-free-diagnostic-platform-181572025-11-06T00:00:00+05:30always0.9https://www.indianpharmapost.com/zydus-wellness-reports-31-growth-in-net-sales-in-q2-fy26-181562025-11-06T00:00:00+05:30always0.9https://www.indianpharmapost.com/novo-nordisk-presents-four-new-analyses-on-oral-semaglutide-25-mg-at-obesityweek-2025-181552025-11-06T00:00:00+05:30always0.9https://www.indianpharmapost.com/senores-pharma-forms-new-subsidiary-in-us-181542025-11-06T00:00:00+05:30always0.9https://www.indianpharmapost.com/teva-reports-11th-consecutive-quarter-of-growth-181672025-11-06T00:00:00+05:30always0.9